Published in AIDS on November 13, 2016
The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis (HCBV) | NCT02905890
The role of family planning in achieving safe pregnancy for serodiscordant couples: commentary from the United States government's interagency task force on family planning and HIV service integration. J Int AIDS Soc (2017) 0.78
Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals? AIDS (2016) 0.78
Sustained effect of couples' HIV counselling and testing on risk reduction among Zambian HIV serodiscordant couples. Sex Transm Infect (2017) 0.76
Safety and Acceptability of Community-Based Distribution of Injectable Contraceptives: A Pilot Project in Mozambique. Glob Health Sci Pract (2016) 0.75
Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial. J Fam Plann Reprod Health Care (2017) 0.75
Predictors of HIV, HIV Risk Perception, and HIV Worry among Adolescent Girls and Young Women in Lilongwe, Malawi. J Acquir Immune Defic Syndr (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS (1993) 10.84
Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis (1991) 7.05
Spurious precision? Meta-analysis of observational studies. BMJ (1998) 5.45
The hazards of hazard ratios. Epidemiology (2010) 5.24
Hormonal contraception and the risk of HIV acquisition. AIDS (2007) 5.05
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33
Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis (1998) 2.96
The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS (1998) 2.80
Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis (2013) 2.70
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS (2007) 2.44
Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis (2015) 2.40
Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr (1993) 2.36
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012. Contraception (2015) 2.11
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol (2006) 2.04
Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr (2010) 2.01
Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev (2009) 1.95
Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception (2007) 1.72
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception (2014) 1.65
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med (2015) 1.61
Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS (2003) 1.60
Incident HIV-1 infection in a cohort of young women in Butare, Rwanda. AIDS (1994) 1.54
Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda. Lancet Glob Health (2015) 1.46
HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda. Sex Transm Dis (2011) 1.45
Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study. Lancet Infect Dis (2015) 1.44
Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS (2012) 1.41
Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months. Sex Transm Dis (2007) 1.39
Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. AIDS (2013) 1.34
Overstating the evidence: double counting in meta-analysis and related problems. BMC Med Res Methodol (2009) 1.33
The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS (2012) 1.26
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25
HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women. AIDS (1998) 1.25
Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis. BJOG (2012) 1.24
Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS (2004) 1.19
Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS (2009) 1.14
Hormonal contraception and HIV-1 transmission. Am J Reprod Immunol (2010) 1.13
Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples. AIDS (2013) 1.13
Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS (2013) 1.11
Baseline factors associated with incident HIV and STI in four microbicide trials. Sex Transm Dis (2010) 1.09
Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.08
HIV incidence in a cohort of women at higher risk in Beira, Mozambique: prospective study 2009-2012. PLoS One (2014) 1.07
HIV-1 incidence among women of reproductive age in Malawi. Int J STD AIDS (2008) 1.04
The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania. PLoS One (2013) 1.00
Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe. AIDS Behav (2014) 0.99
Hormonal contraception and HIV acquisition risk: implications for individual users and public policies. Contraception (2012) 0.99
Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa. BMC Health Serv Res (2001) 0.98
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial. Hum Reprod (2014) 0.98
Preferences between injectable contraceptive methods among South African women. Contraception (2006) 0.96
HIV prevalence and incidence in a cohort of women at higher risk for HIV acquisition in Chókwè, southern Mozambique. PLoS One (2014) 0.91
Contraceptive use and HIV infection in Kenyan family planning clinic attenders. Int J STD AIDS (1996) 0.91
The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception. MBio (2015) 0.89
The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota. AIDS (2013) 0.85
Use of hormonal contraceptives and risk of HIV-1 transmission. Lancet Infect Dis (2012) 0.84
Risk Factors for HIV Acquisition in a Prospective Nairobi-Based Female Sex Worker Cohort. AIDS Behav (2015) 0.83
Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. Contraception (2015) 0.82
The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workers. Sex Transm Dis (2015) 0.81
Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012. AIDS (2015) 0.80
Risk of HIV Infection in Depot-Medroxyprogesterone Acetate (DMPA) Users: A Systematic Review and Meta-analysis. Issues Law Med (2015) 0.78
Multipurpose prevention technologies for sexual and reproductive health: mapping global needs for introduction of new preventive products. Contraception (2015) 0.76
Critical Review: Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism. J Acquir Immune Defic Syndr (2016) 0.75
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr (2004) 6.56
Hormonal contraception and the risk of HIV acquisition. AIDS (2007) 5.05
Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis (2008) 3.98
Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One (2008) 3.94
Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS (2011) 3.61
Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years. BMJ (2013) 3.54
Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med (2010) 3.14
Comparison of group testing algorithms for case identification in the presence of test error. Biometrics (2007) 2.86
Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis (2013) 2.70
Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol (2007) 2.66
Clinical practice. Long-acting methods of contraception. N Engl J Med (2005) 2.65
Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57
Male perspectives on incorporating men into antenatal HIV counseling and testing. PLoS One (2009) 2.55
Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS (2007) 2.35
Ascertaining the size of the symptom iceberg in a UK-wide community-based survey. Br J Gen Pract (2011) 2.33
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Postpartum venous thromboembolism: incidence and risk factors. Obstet Gynecol (2014) 2.21
Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr (2007) 2.21
Contraception for women with systemic lupus erythematosus. J Fam Plann Reprod Health Care (2012) 1.99
Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses (2004) 1.88
Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev (2005) 1.88
Intrauterine device insertion during the postpartum period: a systematic review. Contraception (2009) 1.87
Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr (2008) 1.80
Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. Sex Transm Dis (2009) 1.73
Splines for trend analysis and continuous confounder control. Epidemiology (2011) 1.69
Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res (2010) 1.69
Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS (2010) 1.68
Do people self-reporting information about chronic respiratory disease have corroborative evidence in their general practice medical records? A study of intermethod reliability. Prim Care Respir J (2007) 1.67
The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS (2012) 1.64
Assessing change in chronic pain severity: the chronic pain grade compared with retrospective perceptions. Br J Gen Pract (2002) 1.60
A comparison of methods to estimate the hazard ratio under conditions of time-varying confounding and nonpositivity. Epidemiology (2011) 1.59
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55
A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med (2011) 1.51
International survey on variations in practice of the management of the third stage of labour. Bull World Health Organ (2003) 1.50
Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population. Obstet Gynecol (2015) 1.48
Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief. J Acquir Immune Defic Syndr (2012) 1.44
Factors associated with resilience or vulnerability to hot flushes and night sweats during the menopausal transition. Menopause (2013) 1.41
Accelerating science-driven solutions to challenges in global reproductive health: a new framework for moving forward. Obstet Gynecol (2011) 1.39
Safety of contraceptive use among women with peripartum cardiomyopathy: a systematic review. Contraception (2010) 1.39
Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe. Contraception (2006) 1.37
Contraception for adolescents in low and middle income countries: needs, barriers, and access. Reprod Health (2014) 1.37
Health care provider attitudes and practices related to intrauterine devices for nulliparous women. Obstet Gynecol (2012) 1.36
Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol (2004) 1.36
Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis (2005) 1.34
Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS (2013) 1.33
Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS One (2012) 1.31
The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care. Fam Pract (2008) 1.28
Revisiting the symptom iceberg in today's primary care: results from a UK population survey. BMC Fam Pract (2011) 1.28
Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. AIDS (2005) 1.27
Range of normal neutrophil counts in healthy zimbabwean infants: implications for monitoring antiretroviral drug toxicity. J Acquir Immune Defic Syndr (2006) 1.26
Impact of lifestyle in middle-aged women on mortality: evidence from the Royal College of General Practitioners' Oral Contraception Study. Br J Gen Pract (2010) 1.26
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. PLoS One (2013) 1.24
Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships. AIDS (2012) 1.24
Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception (2005) 1.24
Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion. J Acquir Immune Defic Syndr (2014) 1.23
Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment. J Infect Dis (2010) 1.22
Impact of prior HAART use on clinical outcomes in a large Kenyan HIV treatment program. Curr HIV Res (2009) 1.22
Effect of the UK incentive-based contract on the management of patients with stroke in primary care. Stroke (2006) 1.21
Uptake of prevention of mother to child transmission interventions in Kenya: health systems are more influential than stigma. J Int AIDS Soc (2011) 1.21
Predicting pregnancy in HIV-1-discordant couples. AIDS Behav (2010) 1.20
Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women. AIDS Res Hum Retroviruses (2011) 1.19
Commentary: Epidemiology in the era of big data. Epidemiology (2015) 1.18
Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer (2010) 1.18
Factors related to the onset and persistence of chronic back pain in the community: results from a general population follow-up study. Spine (Phila Pa 1976) (2004) 1.17
Effect of hormonal contraceptive methods on HIV disease progression: a systematic review. AIDS (2013) 1.17
Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research. Sex Transm Dis (2009) 1.16
Reducing unplanned pregnancy and abortion in Zimbabwe through postabortion contraception. Stud Fam Plann (2002) 1.16
Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial. BMJ Open (2013) 1.16
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. PLoS Med (2012) 1.15
Consistent condom use in married Zimbabwean women after a condom intervention. Sex Transm Dis (2008) 1.13
Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa. PLoS One (2012) 1.13
Increased mortality among women with Rose angina who have not presented with ischaemic heart disease. Br J Gen Pract (2003) 1.13
Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception (2005) 1.11
The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav (2011) 1.10
Pain and subsequent mortality and cancer among women in the Royal College of General Practitioners Oral Contraception Study. Br J Gen Pract (2003) 1.10
Unprotected sex following HIV testing among women in Uganda and Zimbabwe: short- and long-term comparisons with pre-test behaviour. Int J Epidemiol (2009) 1.10
Factors associated with age of onset and type of menopause in a cohort of UK women. Am J Obstet Gynecol (2011) 1.08
Size does matter. J Fam Plann Reprod Health Care (2003) 1.08
Barriers to antiretroviral initiation in HIV-1-discordant couples. J Acquir Immune Defic Syndr (2011) 1.06
Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J Acquir Immune Defic Syndr (2005) 1.06
Long term effects of hysterectomy on mortality: nested cohort study. BMJ (2005) 1.06
Sexually transmitted infections among HIV-1-discordant couples. PLoS One (2009) 1.06
Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe. J Acquir Immune Defic Syndr (2011) 1.06
The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One (2008) 1.06
Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. Pharmacoepidemiol Drug Saf (2011) 1.04
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial. Antivir Ther (2008) 1.04
Cost effectiveness of couple counselling to enhance infant HIV-1 prevention. Int J STD AIDS (2008) 1.04
Screening for psychological morbidity in HIV-infected and HIV-uninfected pregnant women using community counselors in Zimbabwe. J Int Assoc Physicians AIDS Care (Chic) (2005) 1.04
Determinants of contraceptive choice among women with HIV. AIDS (2009) 1.04
Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe. Sex Transm Dis (2012) 1.03
Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis (2009) 1.03
Non-cigarette tobacco use among women and adverse pregnancy outcomes. Acta Obstet Gynecol Scand (2010) 1.03
Workload pressures in rural general practice: a qualitative investigation. Scand J Prim Health Care (2002) 1.02
Comparing diagnostic delay in cancer: a cross-sectional study in three European countries with primary care-led health care systems. Fam Pract (2011) 1.02
Reproductive health counseling at pregnancy testing: a pilot study. Contraception (2003) 1.02